Home
/
HCW Biologics Inc.
/
Financials
/
Quarterly
HCW Biologics Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HCW Biologics Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$0
Nov 12, 2021
Q2
2021
Jun 30, 2021
$0
Aug 13, 2021
Q3
2021
Sep 30, 2020
$0
Nov 12, 2021
Q2
2021
Jun 30, 2020
$0
Aug 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.55M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.93M)
Aug 18, 2025
Q3
2025
Jun 30, 2025
($1.93M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($2.20M)
May 15, 2025
Q2
2025
Mar 31, 2025
($2.20M)
Aug 18, 2025
Q3
2025
Mar 31, 2025
($2.20M)
Nov 14, 2025
Q3
2025
Sep 30, 2024
($3.90M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($15.28M)
Aug 18, 2025
Q3
2025
Jun 30, 2024
($15.28M)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($7.47M)
May 15, 2025
Q2
2025
Mar 31, 2024
($7.47M)
Aug 18, 2025
Q3
2025
Mar 31, 2024
($7.47M)
Nov 14, 2025
Q3
2024
Sep 30, 2023
($4.94M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.30M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($4.30M)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($5.07M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($5.07M)
May 15, 2024
Q3
2024
Mar 31, 2023
($5.07M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($3.91M)
Nov 14, 2023
Q3
2023
Jun 30, 2022
($3.51M)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.29M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($3.46M)
Aug 18, 2025
Q1
2025
Mar 31, 2025
($1.97M)
May 15, 2025
Q3
2025
Sep 30, 2024
($3.68M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($15.14M)
Aug 18, 2025
Q1
2025
Mar 31, 2024
($7.49M)
May 15, 2025
Q3
2024
Sep 30, 2023
($5.08M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.51M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($5.36M)
May 15, 2024
Q3
2023
Sep 30, 2022
($4.02M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($3.51M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($1.88M)
Aug 10, 2023
Q3
2022
Sep 30, 2021
($4.09M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($2.75M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($3.41M)
May 13, 2022
Q3
2021
Sep 30, 2020
($2.71M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($2.78M)
Aug 13, 2021